RUNX1 and metabolic dysfunction-associated steatohepatitis: RUNX1 elevated the expression of angiogenic and chemotactic factors and adhesion molecules in HUVEC cells, while these EC properties were abolished after RUNX1 silencing, indicating the involvement of RUNX1 in enhancing inflammation and disease severity in NASH [127].